Abstract
There have been considerable advances in stroke research leading to translation of drug therapy for stroke into the clinical arena. Thrombolysis has significantly reduced disability and revolutionised the manner in which acute ischaemic stroke is treated and anti- platelet agents and anticoagulants have a strong evidence base for the secondary prevention of ischaemic stroke. This article outlines the active approach towards treatment and prevention of ischaemic stroke utilising the antithrombotic medications currently available and highlights the role played by the stroke specialist nurse.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
